this work references cited by second hopReferences
- 2009Business Models, Business Strategy and Innovation8,325 cited
- 2011The Business Model: Recent Developments and Future Research4,791 cited
- 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
- 2007New uses for old drugs1,000 cited
- 2011The productivity crisis in pharmaceutical R&D918 cited
- 1986Generic business strategies, organizational context and performance: An empirical investigation537 cited
- 2007Innovation Policy and the Economy462 cited
- 1992The 4P Classification of the Marketing Mix Revisited447 cited
- 2002Strategic determinants of decisions not to settle patent litigation347 cited
- 2012Evergreening, patent challenges, and effective market life in pharmaceuticals262 cited
- 2000Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry226 cited
- 2010Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration190 cited
- 2010Rare diseases, orphan drugs and their regulation: questions and misconceptions182 cited
- 2007Generic competition and market exclusivity periods in pharmaceuticals169 cited
- 2001Changing the Status of Drugs from Prescription to Over-the-Counter Availability
Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work